Source: Eur Respir J 2014; 43: 1067-1076
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Simpson Jodie L., Phipps Simon, Baines Katherine J., Oreo Kevin M., Gunawardhana Lakshitha, Gibson Peter G.. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J 2014; 43: 1067-1076

Member's Comments

No comment yet.

Related content which might interest you: The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Role of NLRP3 inflammasome and ATP in S100A12-induced MUC5AC production in airway epithelial cells Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung Source: Eur Respir J 2016; 47: 910-918 Year: 2016 The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019 Year: 2020 Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Injury induced inflammasome activation leading to IL-1b and lung inflammation depends on IL-17 Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Rhinovirus triggers increased inflammasome activation in human bronchial epithelium in asthma. Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Activation of the inflammasome pathway during exacerbations of COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1 Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017 Year: 2017 TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Overexpression of suppressor of cytokine signaling-5 augments eosinophilic inflammation in an asthma model Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004